🇮🇳 Libtayo in India

Libtayo (CEMIPLIMAB) regulatory status in India.

Marketing authorisation

CDSCO

  • Status: likely_approved

Libtayo in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Oncology approved in India

Frequently asked questions

Is Libtayo approved in India?

Yes. CDSCO has authorised it.

Who is the marketing authorisation holder for Libtayo in India?

Regeneron Pharmaceuticals is the originator. The local marketing authorisation holder may differ — check the official source linked above.